Get the Stockscreener App
23.80
0.00%
0.00
Precipio Inc stock is traded at $23.80, with a volume of 43,262.
It is up +0.00% in the last 24 hours and down -14.98% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$23.80
Open:
$23.8
24h Volume:
43,262
Relative Volume:
1.42
Market Cap:
$42.54M
Revenue:
$24.05M
Net Income/Loss:
$-363.00K
P/E Ratio:
-80.71
EPS:
-0.2949
Net Cash Flow:
$359.00K
1W Performance:
-3.57%
1M Performance:
-14.98%
6M Performance:
+0.21%
1Y Performance:
+145.99%
1-Day Range:
$22.83
$24.70
1-Week Range:
$22.83
$25.60
52-Week Range:
$9.00
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
23.80 | 42.54M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
448.18 | 166.59B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.81 | 121.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.21 | 44.12B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
338.64 | 33.62B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.08 | 32.49B | 7.07B | 1.29B | 993.00M | 4.5355 |
Precipio Inc Stock (PRPO) Latest News
Precipio director Richard Sandberg sells $22,517 in common stock By Investing.com - Investing.com UK
Precipio director Richard Sandberg sells $22,517 in common stock - Investing.com
Precipio (PRPO) director-linked entity reports 900-share open-market sale - Stock Titan
Number of shareholders of Precipio, Inc. – GETTEX:TGK - TradingView
Precipio Inc. (PRPO) Q2 2025 Earnings: Unexpected Profitability Amid Revenue ChallengesExpert Stock Picks - Newser
Precipio Stock Slides Before Holiday — Why Tuesday’s Open Matters - Bez Kabli
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth - TradingView
Precipio (PRPO) director Sandberg reports 3,134-share net stock sale in Form 4 - Stock Titan
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges By GuruFocus - Investing.com Canada
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Gr - GuruFocus
Earnings call transcript: Precipio Inc Q1 2026 sees revenue growth amid margin pressures - Investing.com Nigeria
Insider sales at PRPO (NASDAQ: PRPO) list 500, 101 and 1,399-share trades - Stock Titan
Q1 2026 Precipio Inc Earnings Call Transcript - GuruFocus
Behavioral Patterns of PRPO and Institutional Flows - Stock Traders Daily
Precipio stock (US74019G1040): cancer diagnostics specialist reports recent financing moves and busi - AD HOC NEWS
Precipio, Inc.Common Stock (NQ: PRPO - The Chronicle-Journal
Precipio stock (US74019G1040): cancer diagnostics specialist in focus after recent financing update - AD HOC NEWS
Precipio (PRPO) Reports Q2 2025 Results — EPS $0.05 Meets ConsensusMost Discussed Stocks - Newser
Precipio (PRPO) CEO Highlights Growth Prospects Amid Flat Revenue - GuruFocus
Precipio Q1 revenue rises on higher pathology sales - TradingView
Precipio Announces Q1 2026 Financial Results - The Manila Times
Precipio Q1 2026 Earnings Call Transcript - MarketBeat
Press Release: Precipio Announces Q1 2026 Financial Results - Moomoo
Surging revenue but going-concern risk for Precipio (NASDAQ: PRPO) in Q1 2026 - Stock Titan
Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Management team’s 2025 market-based Options have vested - The Manila Times
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio - Zacks Investment Research
400% share surge vests Precipio executives' 2025 options - Stock Titan
TradingKey - TradingKey
Ramps Logistics Executes Major Cargo Move for Touchstone’s Cascadura Project - Weekly Voice
B2i Digital Welcomes Precipio, Inc. as a New Featured Company - Weekly Voice
PRPO SEC FilingsPrecipio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precipio Announces Q1 2026 Shareholder Update Call with Live Q&A Session on May 18, 2026 - Minichart
(PRPO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Precipio Announces Q1 2026 Shareholder Update Call - TipRanks
Precipio schedules Q1-2026 shareholder update call May 18 with first moderated live QA - TradingView
Precipio Announces Q1-2026 Shareholder Update Call - The Manila Times
Precipio (NASDAQ: PRPO) sets Q1 2026 update call with live Q&A - Stock Titan
How Precipio (PRPO) earnings power compares to its price (-7.38%) 2026-05-06Community Sell Signals - newser.com
What nobody tells you about Precipio (PRPO) stock (Eye on Rally) 2026-05-05Stock Idea Sharing Hub - Newser
[ARS] Precipio, Inc. SEC Filing - Stock Titan
Precipio (PRPO) details 2026 virtual meeting, director elections and auditor vote - Stock Titan
How (PRPO) Movements Inform Risk Allocation Models - Stock Traders Daily
PRPO (Precipio Inc.) falls 2.41% following Q2 2025 earnings release with no available consensus financial estimates.Pro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Precipio (PRPO) Stock: Is It a Good Entry Point (-2.41%) 2026-04-18Short Term Trading - Xã Thanh Hà
Board member for Precipio (NASDAQ: PRPO) receives 93-share grant - Stock Titan
Stock grant lifts Precipio (PRPO) director Cossman to 16,133 shares - Stock Titan
Precipio (PRPO) director paid in stock grant for Q1 board service - Stock Titan
Trading Systems Reacting to (PRPO) Volatility - Stock Traders Daily
Precipio COO Sabet Ahmed Zaki buys $530 in PRPO stock By Investing.com - Investing.com Australia
Aug Ideas: Is Precipio Inc a good ESG investment2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):